Other3

PRECISION BIOSCIENCES INC

Total Value

$NaN

Filing Date

Aug 3, 2026

1 transactions

Trade Summary

On Aug 1, 2026, Tanna Naresh Haresh, Chief Financial Officer, reported $NaN of PRECISION BIOSCIENCES INC (DTIL) across 1 transactions. The filing covers company securities and reflects balanced net activity of $NaN. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.

Insider Information

Name: Tanna Naresh Haresh
Role: Chief Financial Officer
Location: DURHAM, NC

Filing Details

Filing Date: Aug 3, 2026
Transaction Date: Aug 1, 2026
Accession Number: 0001628280-26-051529
Form Type: 3

Want live alerts when Tanna Naresh Haresh trades again?

Download Insider Trades to track DTIL, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.

iOS App Android App

Footnotes

(F1)On April 18, 2024, the reporting person was granted 16,683 restricted stock units ("RSUs"), which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
(F2)The Reporting Person was granted RSUs, which each represents a contingent right to receive one share of the Company's Common Stock.
(F3)On August 22, 2024, the reporting person was granted 33,317 RSUs, which vest in three substantially equal annual installments beginning on January 27, 2025, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
(F4)On June 2, 2025, the reporting person was granted 45,000 RSUs, which vest in three substantially equal annual installments beginning on February 17, 2026, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
(F5)On June 1, 2026, the reporting person was granted 179,340 RSUs, which vest in three substantially equal annual installments beginning on February 19, 2027, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Tanna Naresh Haresh

(Last)

(First)

(Middle)

C/O PRECISION BIOSCIENCES, INC.

302 E. PETTIGREW STREET, SUITE A-100

(Street)

DURHAM

27701

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/01/2026

3. Issuer Name and Ticker or Trading Symbol
PRECISION BIOSCIENCES INC [ DTIL ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	25,575	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Restricted Stock Units	⁽¹⁾	⁽¹⁾	Common Stock	5,561	⁽²⁾	D
Restricted Stock Units	⁽³⁾	⁽³⁾	Common Stock	11,105	⁽²⁾	D
Restricted Stock Units	⁽⁴⁾	⁽⁴⁾	Common Stock	30,000	⁽²⁾	D
Restricted Stock Units	⁽⁵⁾	⁽⁵⁾	Common Stock	179,340	⁽²⁾	D

Explanation of Responses:

1. On April 18, 2024, the reporting person was granted 16,683 restricted stock units ("RSUs"), which vest in three substantially equal annual installments beginning on January 20, 2025, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

2. The Reporting Person was granted RSUs, which each represents a contingent right to receive one share of the Company's Common Stock.

3. On August 22, 2024, the reporting person was granted 33,317 RSUs, which vest in three substantially equal annual installments beginning on January 27, 2025, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

4. On June 2, 2025, the reporting person was granted 45,000 RSUs, which vest in three substantially equal annual installments beginning on February 17, 2026, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

5. On June 1, 2026, the reporting person was granted 179,340 RSUs, which vest in three substantially equal annual installments beginning on February 19, 2027, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Dario Scimeca, Attorney-in-Fact for Naresh Tanna	08/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Form 3 as rendered by the SEC from accession 0001628280-26-051529.

PRECISION BIOSCIENCES INC

Trade Summary

Company Information

Insider Information

Filing Details

Want live alerts when Tanna Naresh Haresh trades again?

Footnotes

SEC Form 3

SEC Filing

SEC Form 3